SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 165.08 |
| Enterprise Value ($M) | 150.38 |
| Book Value ($M) | -1.79 |
| Book Value / Share | -0.06 |
| Price / Book | -92.34 |
| NCAV ($M) | 14.72 |
| NCAV / Share | 0.47 |
| Price / NCAV | 11.21 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -49.72 |
| Return on Assets (ROA) | -0.41 |
| Return on Equity (ROE) | -1.89 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.63 |
| Current Ratio | 1.63 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 50.86 |
| Assets | 58.73 |
| Liabilities | 36.13 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 25.18 |
| Operating Income | -23.86 |
| Net Income | -22.29 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -25.60 |
| Cash from Investing | 5.11 |
| Cash from Financing | 25.58 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Highbridge Capital Management Llc | 9.10 | ||
| 13G | Nippon Shinyaku Co Ltd | 6.97 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 74,348 | 248,160 | 29.96 | |
| 47,193 | 179,362 | 26.31 | |
| 46,817 | 37,198 | 125.86 | |
| 61,875 | 53,114 | 116.49 | |
| 93,135 | 99,098 | 93.98 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| BTAI – BioXcel Therapeutics, Inc. | BYSI – BeyondSpring Inc. |
| CALC – CalciMedica, Inc. | CASI – CASI Pharmaceuticals, Inc. |
| CDIO – Cardio Diagnostics Holdings, Inc. |